Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction
NCT00036231 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2005-11-21
Summary
The purpose of the study is to determine the effect of multiple doses of secretin on autism.
Conditions
Interventions
- DRUG
-
RG1068 (Synthetic Human Secretin)
Sponsors & Collaborators
-
Repligen Corporation
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 32 Months
- Max Age
- 59 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-04-30
More Related Trials
-
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial
NCT04881825 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease
NCT06272149 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Study of VYNT-0126 in the Treatment of Rett Syndrome in Adult Patients
NCT05625568 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of RO4917523 in Pediatric Patients With Fragile X Syndrome
NCT01750957 ·Status: COMPLETED ·Phase: PHASE2
-
A Single-Dose Study in Normal Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of STX107
NCT00965432 ·Status: COMPLETED ·Phase: PHASE1
-
To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome
NCT06849973 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Eliglustat in Chinese Pediatric Patients With Gaucher Disease Type 1 and Type 3
NCT06523517 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants
NCT05670951 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)
NCT06152237 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Safety and EffIcacy of PRX-102 on Gastrointestinal Symptoms in Naïve Fabry Disease
NCT02921620 ·Status: WITHDRAWN ·Phase: PHASE3
-
SynapDx Autism Gene Expression Analysis Study
NCT01716845 ·Status: COMPLETED
-
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
NCT02715115 ·Status: COMPLETED ·Phase: PHASE2
-
RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome)
NCT04571970 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease
NCT00319046 ·Status: COMPLETED ·Phase: PHASE3
-
ANAVEX2-73 Study in Patients With Rett Syndrome
NCT03941444 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS
NCT03905707 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Long-term Effect on Intestinal Absorption and Safety of Treatment With Glepaglutide in Patients With Short Bowel Syndrome
NCT04991311 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Extension of GTX-102 in Angelman Syndrome
NCT06415344 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Establishing a Diagnostic and Therapeutic Index in Autism Spectrum Disorder (ASD) and Fragile X Syndrome
NCT04869930 ·Status: UNKNOWN
-
Study to Assess Safety and Efficacy of Fingolimod in Children With Rett Syndrome
NCT02061137 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)
NCT03614663 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome
NCT01325740 ·Status: SUSPENDED ·Phase: PHASE2
-
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
NCT02790034 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome
NCT05541003 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome
NCT02365506 ·Status: COMPLETED ·Phase: PHASE1